онкоБЛОГия Telegram | DID YOU KNOW?
Date: | онкоБЛОГия
What distinguishes the app from competitors is its use of what's known as channels: Public or private feeds of photos and videos that can be set up by one person or an organization. The channels have become popular with on-the-ground journalists, aid workers and Ukrainian President Volodymyr Zelenskyy, who broadcasts on a Telegram channel. The channels can be followed by an unlimited number of people. Unlike Facebook, Twitter and other popular social networks, there is no advertising on Telegram and the flow of information is not driven by an algorithm. Soloviev also promoted the channel in a post he shared on his own Telegram, which has 580,000 followers. The post recommended his viewers subscribe to "War on Fakes" in a time of fake news. In December 2021, Sebi officials had conducted a search and seizure operation at the premises of certain persons carrying out similar manipulative activities through Telegram channels. On Telegram’s website, it says that Pavel Durov “supports Telegram financially and ideologically while Nikolai (Duvov)’s input is technological.” Currently, the Telegram team is based in Dubai, having moved around from Berlin, London and Singapore after departing Russia. Meanwhile, the company which owns Telegram is registered in the British Virgin Islands. The regulator took order for the search and seizure operation from Judge Purushottam B Jadhav, Sebi Special Judge / Additional Sessions Judge.
онкоБЛОГия from ms
онкоБЛОГияРеальная история женщины хирурга-онколога от А до Я. Случаи из практики. Профилактика непоправимого.
Вопросы и пожелания автору: @dNatalya
Коммерческое взаимодействие: @tyvlv
Вопросы и пожелания автору: @dNatalya
Коммерческое взаимодействие: @tyvlv
онкоБЛОГия
group-telegram.com/onkoblog
American US telegram Group & telegram Channel 10
Created:
From: American and France
Telegram онкоБЛОГия, 332917 Telegram Group & Telegram Channel American, USTelegram онкоБЛОГия, 332917 Telegram Group & Telegram Channel, France, FR
https://t.me/onkoblog
Webview